PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
MetadataShow full item record
Other Language Versions
PAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects.The information included in this note reflects the available evidence at the date of publication.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2021-08-13)This publication presents the set of new and revised Pan American Health Organization (PAHO) Regional Sodium Reduction Targets 2021–2025 adopted by the PAHO Technical Advisory Group on Cardiovascular Disease Prevention ...
Front-of-Package Labeling as a Policy Tool for the Prevention of Noncommunicable Diseases in the Americas Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2020-09-25)High blood pressure, high fasting blood sugar levels (measured as fasting plasma glucose), and overweight/obesity are the top three risk factors for mortality in the Americas. Unhealthy eating is closely linked to these ...
Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2021-03-05)This fact-sheet presents the results of the first study to take place in the Caribbean to examine the best performing front-of-package labeling (FOPL). It was conducted by the Ministry of Health and Wellness of Jamaica, ...